RTX Analysts Split on How Much the Earnings Bounce Has to Run

RTX Corporation sits just above $194 this week, a dollar higher than last Tuesday's close but with the Street divided on whether the post-earnings rally has further legs.

The analyst picture is the most telling data point right now. Since the Q3 print on October 20, the direction of travel has been upward on targets but uneven on conviction. Barclays, which initiated at Overweight with a $223 target on October 9, raised to $235 within two weeks of the earnings release, a fast validation of its bullish case. UBS moved its target to $212 from $209 while staying Neutral, a modest concession to positive momentum without changing the rating. The more cautious signals came earlier in the month: RBC cut its Outperform target to $235 from $250, and both Bernstein and TD Cowen trimmed targets before the print. The consensus mean of $229 sits roughly 18% above the current price, but the spread of targets captures the disagreement well. Bulls point to a $289 billion backlog, 22% year-on-year growth in that backlog, Raytheon's 18% organic expansion, and management raising full-year guidance on sales, EPS, and free cash flow. Bears worry about a slower commercial aerospace recovery, persistent supply chain bottlenecks in rocket motors, engine castings, and microelectronics, and the ongoing GTF engine situation at Pratt & Whitney. RTX ranks in the 97th percentile on analyst recommendation differentiation, a factor score that reflects just how much upside the consensus still formally sees. EV/EBITDA has eased about half a turn over the past 30 days to around 16.6x, and the PE of 24.4x is essentially flat over the same period, suggesting the multiple has absorbed the earnings beat rather than expanded further.

On the positioning side, there is very little to worry about for longs and not much to excite shorts. Short interest edged up 3.1% over the past week to 1.1% of the free float, continuing a gradual rebuild from mid-September lows. That monthly rise of roughly 14.5% in shares short is worth noting, but the absolute level remains low enough that it represents normal noise around an index-weight name rather than a thesis-driven build. Borrow conditions confirm this reading. Availability is effectively uncapped, with over 1.1 billion shares available to borrow against fewer than 16 million shares short. Cost to borrow is 0.36%, essentially free. The put/call ratio at 0.90 is modestly above its 20-day average of 0.86 by less than one standard deviation, well short of the past year's high of 1.02. Options positioning looks slightly more cautious than a month ago, when the ratio was tracking in the low 0.75 to 0.78 range, but there is no sign of a meaningful defensive push.

One data point from the alt data layer is worth flagging. RTX's Wikipedia page views registered a z-score of 2.6 against its own trailing 90 days as of October 21, placing retail attention at an elevated level relative to recent history. None of the six alt data datasets covering RTX have been measured to lead the company's reported figures, so this reads as a reflection of the post-earnings news cycle rather than a forward signal. The next earnings event is scheduled for January 19, 2027, giving the Street 83 days to form a view on whether Q4 execution holds the backlog-conversion thesis together.

Among peers, LMT gained 13.5% over the past week against RTX's 0.65%, a gap that reflects Lockheed's own earnings dynamic rather than relative positioning. NOC added 3.2%, and LHX rose 4.3%. The next milestone for RTX is squarely the January print and whether management's raised guidance holds, particularly on free cash flow, which the bear case puts closer to $10.2 billion against a more optimistic target.